Drug industry unable to meet demand for broad coronavirus testing




Whatsapp News

COVID-19

Geneva – industry cannot enough diagnostic kits for novel coronavirus meet the World Organisation’ recommendation for broad testing efforts.

A leading pharmaceutical executive says on Thursday.

“Whilst industry has been ramping up production, and as more testing capacities are provided, still the demand is by far outstripping the supply,’’ Roche chief executive Severin Schwann said at a briefing of the International of Pharmaceutical Manufacturers and Associations (IFPMA).

Testing should, therefore, be focused on high-risk patients and those who show symptoms of Covid-19 viral disease, he said.

“Broad-based testing at this time is simply not feasible,’’ Schwann added.(dpa/NAN)